BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7850585)

  • 1. First-trimester nuchal edema as a marker of aneuploidy.
    Comas C; Martinez JM; Ojuel J; Casals E; Puerto B; Borrell A; Fortuny A
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):26-9. PubMed ID: 7850585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonography of the fetal neck in the first and second trimesters. Part 2. Anomalies of the posterior nuchal region.
    Suchet IB
    Can Assoc Radiol J; 1995 Oct; 46(5):344-52. PubMed ID: 7552826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].
    Tercanli S; Holzgreve W; Batukan C; Gerber A; Ermis H; Miny P
    Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling.
    Brambati B; Cislaghi C; Tului L; Alberti E; Amidani M; Colombo U; Zuliani G
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):9-14. PubMed ID: 7850598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuchal translucency in the first trimester.
    Hewitt B
    Aust N Z J Obstet Gynaecol; 1993 Nov; 33(4):389-91. PubMed ID: 8179549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin edema in first trimester fetuses.
    Jenewein N; Christ J; Günther D; Hutsteiner P; Ortmann O; Germer U
    Ultraschall Med; 2013 Oct; 34(5):441-5. PubMed ID: 23696062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
    BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester translucency: aneuploidy, sonographic findings, and maternal age.
    Mahieu-Caputo D; Dommergues M; Morichon-Delvallez N; Aubry MC; Wekemans M; Dumez Y
    Fetal Diagn Ther; 1996; 11(3):199-204. PubMed ID: 8739587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal 'space-suit' hydrops in the first trimester: differentiating risk for chromosome abnormalities by delineating characteristics of nuchal translucency.
    Shulman LP; Phillips OP; Emerson DS; Felker RE; Tharapel AT
    Prenat Diagn; 2000 Jan; 20(1):30-2. PubMed ID: 10701847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age.
    Szabó J; Gellén J; Szemere G
    Ultrasound Obstet Gynecol; 1995 Mar; 5(3):161-3. PubMed ID: 7788489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal karyotype results of fetuses with nuchal edema, cystic hygroma, and non-immune hydrops.
    Gezer C; Ekin A; Gezer NS; Ertas IE; Avci ME; Uyar I; Ciftci S; Taner CE
    Clin Exp Obstet Gynecol; 2015; 42(5):586-9. PubMed ID: 26524803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
    Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuchal thickening or cystic hygromas in first- and early second-trimester fetuses: prognosis and outcome.
    Nadel A; Bromley B; Benacerraf BR
    Obstet Gynecol; 1993 Jul; 82(1):43-8. PubMed ID: 8515924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.